Summary
This document is a technical report that discusses the importance of carrier screening in identifying recessive genetic disorders that couples may pass on to their children. It outlines how expanded carrier screening can facilitate pan-ethnic risk assessment for multiple disorders through a single test, thereby improving the chances of identifying affected pregnancies. The report features insights from Dr. Shareef Nahas, Chief Scientific Officer at Sampled, who explains the company's approach to preconception carrier screening, including the use of a comprehensive microarray for accurate identification. The document details the services offered by Sampled, including sample processing and data analysis, and highlights the significance of ethnicity in interpreting genetic variants. It also addresses challenges in data interpretation and the automation of reporting processes. The report concludes with a discussion on the future of carrier screening, particularly the potential role of next-generation sequencing as costs decrease and technology advances.
